Bronchoprotective mechanisms for specialized pro-resolving mediators in the resolution of lung inflammation
Authors:
- 1 December 2017
- journal article
- review article
- Published by Elsevier in Molecular Aspects of Medicine
- Vol. 58, 44-56
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (R01-HL122531, U01-HL108712, U10-HL109172, U24-AI118656, P01-GM095467, K12-HD047349)
- Sao Paulo Research Foundation (FAPESP) (2015/26048-5)
This publication has 122 references indexed in Scilit:
- Chemerin15 inhibits neutrophil‐mediated vascular inflammation and myocardial ischemia‐reperfusion injury through ChemR23EMBO Reports, 2013
- High levels of anti-inflammatory and pro-resolving lipid mediators lipoxins and resolvins and declining docosahexaenoic acid levels in human milk during the first month of lactationLipids in Health and Disease, 2013
- Maresin-1 reduces the pro-inflammatory response of bronchial epithelial cells to organic dustRespiratory Research, 2013
- Toll‐like receptor 7 stimulates production of specialized pro‐resolving lipid mediators and promotes resolution of airway inflammationEMBO Molecular Medicine, 2013
- Resolvin D1 Receptor Stereoselectivity and Regulation of Inflammation and Proresolving MicroRNAsThe American Journal of Pathology, 2012
- Resolvin E1 maintains macrophage function under cigarette smoke‐induced oxidative stressFEBS Open Bio, 2012
- Lovastatin decreases acute mucosal inflammation via 15-epi-lipoxin A4Mucosal Immunology, 2010
- Neuroprotectin D1/protectin D1 stereoselective and specific binding with human retinal pigment epithelial cells and neutrophilsProstaglandins, Leukotrienes and Essential Fatty Acids, 2010
- Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsisNature, 2009
- Resolvin E1 regulates interleukin 23, interferon-γ and lipoxin A4 to promote the resolution of allergic airway inflammationNature Immunology, 2008